SCHEMBL4391467

SCHEMBL4391467

CCCC(=O)C=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16123051 0.85 CES1 (0.36)
SCHEMBL13039627 0.85 ALDH1A1 (0.39)
SCHEMBL3635304 0.84 CES1 (0.48)
SCHEMBL454224 0.82 TRPA1 (0.52)
SCHEMBL11152980 0.81 CES1 (0.41)
SCHEMBL19599288 0.81 CES1 (0.41)
SCHEMBL11152978 0.81 CES1 (0.41)
SCHEMBL28063791 0.81
SCHEMBL3912771 0.80 CES2 (0.52)
SCHEMBL11747932 0.80 CES2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007221-A1 CAROTENOID-CONTAINING DIETARY SUPPLEMENT Chemaphor Inc. (CA) 2008-12-31 EP claimed
WO-2007112587-A1 CAROTENOID-CONTAINING DIETARY SUPPLEMENT CHEMAPHOR INC. (CA) 2007-10-11 WO claimed
US-5331086-A Deashing process for polyolefins using an alpha,beta-unsaturated ketone PHILLIPS PETROLEUM COMPANY (US) 1994-07-19 US claimed
US-12458679-B2 Composition for inhibiting TNF-α or IL-6 production HOUSE WELLNESS FOODS CORPORATION (JP) 2025-11-04 US disclosed
US-12295920-B2 Composition for treatment, prevention, or amelioration of Alzheimer's disease, a composition for suppression of brain nerve cell death, a composition for suppression of microglia activation induced by amyloid β peptide, and a composition for suppression of PGE2, TNF-α, or IL-1β production induced by amyloid βpeptide HOUSE WELLNESS FOODS CORPORATION (JP) 2025-05-13 US disclosed
CN-119752742-A Pre-harvest physiological management method for improving color and smell quality of spirulina 中国海洋大学 2025-04-04 CN disclosed
WO-2025057927-A1 COMPOSITION FOR PROMOTING OR IMPROVING RENAL FUNCTION ハウスウェルネスフーズ株式会社 2025-03-20 WO disclosed
WO-2025028304-A1 COMPOSITION FOR IMPROVING INSULIN RESISTANCE ハウスウェルネスフーズ株式会社 2025-02-06 WO disclosed
CN-114126594-B Compositions for inhibiting TNF-alpha or IL-6 production 好侍健康食品株式会社 2024-06-14 CN disclosed
US-11931396-B2 Composition for improving vascular endothelial function or improving blood flow in peripheral blood vessels HOUSE WELLNESS FOODS CORPORATION (JP) 2024-03-19 US disclosed
US-20230242548-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-08-03 US disclosed
EP-2007221-A1 CAROTENOID-CONTAINING DIETARY SUPPLEMENT Chemaphor Inc. (CA) 2008-12-31 EP disclosed
WO-2008151183-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2008-12-11 WO disclosed
US-20080300268-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2008-12-04 US disclosed
US-7338973-B2 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators JANSSEN PHARMACEUTICA N.V. (BE) 2008-03-04 US disclosed
WO-2007112587-A1 CAROTENOID-CONTAINING DIETARY SUPPLEMENT CHEMAPHOR INC. (CA) 2007-10-11 WO disclosed
US-5331086-A Deashing process for polyolefins using an alpha,beta-unsaturated ketone PHILLIPS PETROLEUM COMPANY (US) 1994-07-19 US disclosed
US-4002684-A FROM AN ALPHA,BETA-UNSATURATED KETONE AND A VINYLMAGNESIUM HALIDE, COPPER COMPOUND CATALYST BASF AKTIENGESELLSCHAFT (DT) 1977-01-11 US disclosed
US-3994936-A Catalytic rearrangement HOFFMANN-LA ROCHE INC. (US) 1976-11-30 US disclosed
US-3981896-A CONVERSION OF ACETYLENIC ALCOHOLS TO ALDEHYDES AND KETONES HOFFMANN-LA ROCHE INC. (US) 1976-09-21 US disclosed